Abstract 5591: Circulating tumor DNA for recurrence prediction and efficacy analysis in the ICONIC trial of peri-operative FLOT and avelumab (PD-L1) in localized esophago-gastric adenocarcinoma
Volume
83
Pagination
5591 - 5591
Publisher
DOI
10.1158/1538-7445.am2023-5591
Journal
Cancer Research
Issue
ISSN
0008-5472